Release Date: 31/01/12 08:25 Summary: Quarterly Activities and Cashflow Report - December 2011 Price Sensitive: Yes Download Document 1.96MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%